Lipodystrophy among HIV-infected children and adolescents on highly active antiretroviral therapy in Uganda: a cross sectional study (Q36386822)

13 August 2017

Lipodystrophy among HIV-infected children and adolescents on highly active antiretroviral therapy in Uganda: a cross sectional study (English)

1 reference

13 August 2017

0 references

anti-retroviral agent

0 references

1 reference

4

Moses R Kamya

1 reference

13 August 2017

Sabrina Bakeera-Kitaka

series ordinal

2

object named as

Sabrina Bakeera-Kitaka

1 reference

13 August 2017

Thereza Piloya

1

1 reference

13 August 2017

Adeodata Kekitiinwa

series ordinal

3

1 reference

13 August 2017

language of work or name

1 reference

2 July 2012

1 reference

Journal of the International AIDS Society

13 August 2017

1 reference

13 August 2017

15

1 reference

13 August 2017

2

1 reference

13 August 2017

17427

1 reference

LIPODYSTROPHY SYNDROME IN HIV-INFECTED CHILDREN ON HAART.

13 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3494170

Discontinuation of standard first-line antiretroviral therapy in a cohort of 1434 Malawian children

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3494170

Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3494170

Metabolic complications of antiretroviral therapy in children

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3494170

Adverse effects of antiretroviral therapy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3494170

Monitoring of lipodystrophic and metabolic abnormalities in HIV-1 infected children on antiretroviral therapy.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3494170

Prevalence of lipodystrophy in HIV-infected children: a cross-sectional study.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3494170

Detection of lipoatrophy in human immunodeficiency virus-1-infected children treated with highly active antiretroviral therapy

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3494170

Longitudinal evaluation and risk factors of lipodystrophy and associated metabolic changes in HIV-infected children.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3494170

Prevalence of fat redistribution and metabolic disorders in human immunodeficiency virus-infected children.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3494170

Antiretroviral therapy, fat redistribution and hyperlipidaemia in HIV-infected children in Europe

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3494170

Combination antiretroviral therapy and the risk of myocardial infarction

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3494170

Increased risk of lipoatrophy under stavudine in HIV-1-infected patients: results of a substudy from a comparative trial

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3494170

Lipodystrophy syndrome in human immunodeficiency virus-infected children

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3494170

Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3494170

Clinical and metabolic presentation of the lipodystrophic syndrome in HIV-infected children

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3494170

Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3494170

Screening for lipid disorders in children: US Preventive Services Task Force recommendation statement

21 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22814353

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Relationship between HAART adherence and adipose tissue alterations

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22814353

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Abnormal body-fat distribution in HIV-1-infected children on antiretrovirals

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22814353

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.7448/IAS.15.2.17427

1 reference

13 August 2017

1 reference

13 August 2017

PubMed publication ID

22814353

1 reference